Genmab and Synaffix Enter into License Agreement for ADC Technology
January 04, 2022 09:00 ET
|
Genmab A/S
Media Release Synaffix to provide access to proprietary antibody-drug conjugate (ADC) technologiesGenmab secures rights for conducting research on ADCs against multiple drug targets with options for...
Global Antibody Drug Conjugates Contract Manufacturing Market (2021 to 2028) - Featuring Lonza, Catalent and Siegfried Among Others
November 02, 2021 08:48 ET
|
Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract Manufacturing Market Size, Share & Trends Analysis Report By Condition (Myeloma, Lymphoma, Breast Cancer), By...
Global Antibody Drug Conjugates Market Research 2021 Featuring Major Players - Bayer, Concortis Biotherapeutics, F. Hoffman-La Roche, Immunomedics, and Oxford BioTherapeutics
October 20, 2021 09:23 ET
|
Research and Markets
Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Insights on the Antibody Drug Conjugates Global Market to 2030 - Featuring 6 Dimensions Capital, AbbVie and ABL Bio Among Others
October 08, 2021 05:58 ET
|
Research and Markets
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market by Indication, Linker, Payload, Target Antigens and Geography: Industry Trends and Global Forecasts, 2021-2030" report...
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
October 06, 2021 07:13 ET
|
Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...
Global $23.9 Billion Antibody Drug Conjugate Markets to 2028: Major Players are Entering into Partnerships for Development & Commercialization
September 16, 2021 04:38 ET
|
Research and Markets
Dublin, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugate Market" report has been added to ResearchAndMarkets.com's offering. The global antibody drug conjugate market size is...
Tasrif Pharmaceutical Announces Grant of U.S. Patent for Humanized Monoclonal Antibodies against the Poliovirus Receptor
August 25, 2021 12:00 ET
|
Tasrif Pharmaceutical, LLC
BOSTON, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Tasrif Pharmaceutical announces the grant of a US Patent related to its proprietary humanized monoclonal antibodies against the poliovirus receptor (a.k.a....
Antibody Drug Conjugates Market CAGR predicted at 15.4% by 2031: Visiongain Research Inc.
July 08, 2021 10:31 ET
|
Visiongain Ltd
Visiongain has published a new report on Global Antibody Drug Conjugates Market Report Forecast 2021-2031. Forecasts : By Technology (Cleavable Linkers, Non-Cleavable Linkers, Other Technology), By...
Global $10 Billion Bi-Specific MAbS Markets, 2015-2020, 2020-2025F, 2030F
June 23, 2021 05:48 ET
|
Research and Markets
Dublin, June 23, 2021 (GLOBE NEWSWIRE) -- The "Bi-Specific MAbS Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...
Global Antibody Partnering Deals, Terms and Agreements Report 2021
June 11, 2021 05:38 ET
|
Research and Markets
Dublin, June 11, 2021 (GLOBE NEWSWIRE) -- The "Global Antibody Partnering Terms and Agreements 2014-2021" report has been added to ResearchAndMarkets.com's offering. The Global Antibody Partnering...